Research Project History
| PI / Project Leader | MULLAN, MICHAEL |
|---|---|
| Awardee Organization | ARCHER PHARMACEUTICALS, INC. |
| Funding Agency/Organization | NIA |
| Sub-Project Number | None |
Updates
| Project Number | FY | FY Funding Amount | Project Title |
|---|---|---|---|
| 5R42AG062063-03 | 2021 | $699018 | Development of Spleen Tyrosine Kinase (SYK) negative allosteric modifiers for therapeutic intervention in Alzheimer's disease. |
| 4R42AG062063-02 | 2020 | $812379 | Development of Spleen Tyrosine Kinase (SYK) negative allosteric modifiers for therapeutic intervention in Alzheimer's disease. |
| 1R42AG062063-01 | 2018 | $224920 | Development of Spleen Tyrosine Kinase (SYK) negative allosteric modifiers for therapeutic intervention in Alzheimers disease. |